Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare reflex epilepsy characterized by reading-induced seizures which in most cases present with orofacial/jaw myoclonus possibly extending to the upper limbs but can also manifest as dyslexia or alexia and visual symptoms. In both variants secondary generalized tonic-clonic seizures may evolve if the stimulus is not interrupted. The disease typically begins in the second or third decade of life and may be inherited in an autosomal dominant pattern. It usually takes a benign course with little tendency to spontaneous seizures.
Features include: EEG abnormality and Seizure.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 1 | Seizure |
Biomarker and diagnostic research for reading seizures has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for reading seizures.
173 publications have been identified in PubMed for reading seizures. Research spans Case Report / Case Series (34%), Basic Science / Preclinical (27%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 58 | 34% |
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 11:44 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
47 |
27% |
Disease patterns and progression | 22 | 13% |
Clinical study results | 17 | 10% |
Testing and diagnosis research | 10 | 6% |
Research summaries | 10 | 6% |
Other research | 5 | 3% |
New treatment approaches | 4 | 2% |
Ranpariya M (2026). [PMID: 41652275](https://pubmed.ncbi.nlm.nih.gov/41652275/). *Epileptic Disord*. [Case Report / Case Series]
Atacan Yaşgüçlükal M (2026). [PMID: 41032687](https://pubmed.ncbi.nlm.nih.gov/41032687/). *Clin EEG Neurosci*. [Clinical Trial Publication]
Kasana R (2026). [PMID: 42241354](https://pubmed.ncbi.nlm.nih.gov/42241354/). *Ann Indian Acad Neurol*. [Diagnostic / Biomarker]
Luisi C (2026). [PMID: 42276780](https://pubmed.ncbi.nlm.nih.gov/42276780/). *J Nucl Med*. [Diagnostic / Biomarker]
Sun X (2026). [PMID: 42281002](https://pubmed.ncbi.nlm.nih.gov/42281002/). *Sensors (Basel)*. [Basic Science / Preclinical]
Yang XL (2026). [PMID: 42066538](https://pubmed.ncbi.nlm.nih.gov/42066538/). *Seizure*. [Case Report / Case Series]
Aziz R (2026). [PMID: 42017716](https://pubmed.ncbi.nlm.nih.gov/42017716/). *J Pak Med Assoc*. [Epidemiology / Natural History]
Cao DW (2026). [PMID: 42081258](https://pubmed.ncbi.nlm.nih.gov/42081258/). *Epileptic Disord*. [Case Report / Case Series]
Bhanudeep S (2026). [PMID: 41572370](https://pubmed.ncbi.nlm.nih.gov/41572370/). *Ann Indian Acad Neurol*. [Case Report / Case Series]
Samanta D (2026). [PMID: 42161154](https://pubmed.ncbi.nlm.nih.gov/42161154/). *Epilepsy Behav*. [Review / Meta-Analysis]